Home › Trial NCT06418126
Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer
- Trial IDNCT06418126
- StatusActive Not Recruiting
- PhaseN/A
- Study typeInterventional
- SponsorCentre Paul Strauss
- Enrollment15
- Start date2024-01-11
- ConditionsTriple-negative Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.